These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 38741927

  • 1. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study.
    Jun YK, Ji E, Yang HR, Choi Y, Shin CM, Park YS, Kim N, Lee DH, Yoon H.
    Therap Adv Gastroenterol; 2024; 17():17562848241248321. PubMed ID: 38741927
    [Abstract] [Full Text] [Related]

  • 2. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM, Lijftogt T, Kindermann A, Damen G, de Ridder L, Escher JC, Mearin ML, de Meij T, Hendriks D, George E, Hummel T, Norbruis O, van Rheenen P.
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [Abstract] [Full Text] [Related]

  • 3. Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.
    Boyle BM, Kappelman MD, Colletti RB, Baldassano RN, Milov DE, Crandall WV.
    World J Gastroenterol; 2014 Jul 21; 20(27):9185-90. PubMed ID: 25083093
    [Abstract] [Full Text] [Related]

  • 4. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 5. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ, Pediatric Inflammatory Bowel Disease Collaborative Research Group.
    Inflamm Bowel Dis; 2014 Aug 01; 20(8):1341-5. PubMed ID: 24983976
    [Abstract] [Full Text] [Related]

  • 6. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U, Katsanos KH, van der Woude CJ, Karmiris K, Hernandez V, Odes S, Papamichael K, Koutroubakis IE, Bojic D, Kaimakliotis I, Fiorino G, Papageorgiou N, Pineda JR, Strongili K, Sanroman L, Mantzaris GJ, Jojic N, Paspatis G, Christodoulou DK, Ben-Horin S, Tsianos EV.
    Eur J Gastroenterol Hepatol; 2016 Jul 01; 28(7):802-6. PubMed ID: 26894634
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Thiopurines in Biologic-Naive Japanese Patients With Crohn's Disease: A Single-Center Experience.
    Yoshino T, Matsuura M, Minami N, Yamada S, Honzawa Y, Kimura M, Koshikawa Y, Madian A, Toyonaga T, Nakase H.
    Intest Res; 2015 Jul 01; 13(3):266-73. PubMed ID: 26131002
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Barber GE, Hendler S, Choe M, Keyashian K, Lechner S, Limketkai BN, Limsui D.
    Dig Dis Sci; 2022 Apr 01; 67(4):1287-1294. PubMed ID: 33755823
    [Abstract] [Full Text] [Related]

  • 9. Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.
    Mantzaris GJ.
    Curr Treat Options Gastroenterol; 2017 Mar 01; 15(1):84-104. PubMed ID: 28160250
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and Tolerability of Methotrexate Combined with Biologics in Patients with Crohn's Disease: A Multicenter Observational Study.
    Park J, Chun J, Park SJ, Park JJ, Kim TI, Yoon H, Cheon JH.
    Dig Dis Sci; 2024 Mar 01; 69(3):901-910. PubMed ID: 38217678
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
    Huang Z, Chao K, Li M, Zhi M, Tang J, Hu P, Gao X.
    Inflamm Bowel Dis; 2017 Mar 01; 23(3):440-447. PubMed ID: 28129286
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study.
    Kim YZ, Kang B, Kim ES, Kwon Y, Choe YH, Kim MJ.
    Biomedicines; 2023 Sep 19; 11(9):. PubMed ID: 37761016
    [Abstract] [Full Text] [Related]

  • 13. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
    Singh JA, Hossain A, Mudano AS, Tanjong Ghogomu E, Suarez-Almazor ME, Buchbinder R, Maxwell LJ, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2017 May 08; 5(5):CD012657. PubMed ID: 28481462
    [Abstract] [Full Text] [Related]

  • 14. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy].
    Choi JR, Yun GW, Park YM, Kim JH, Youn YH, Park HJ, Park JJ.
    Korean J Gastroenterol; 2015 Oct 08; 66(4):231-6. PubMed ID: 26493510
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Wang Y, Tsoulis DJ, MacDonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2014 Aug 06; 2014(8):CD003459. PubMed ID: 25099640
    [Abstract] [Full Text] [Related]

  • 16. Thiopurines Have Longer Treatment Durability than Methotrexate in Adults and Children with Crohn's Disease: A Nationwide Analysis from the epi-IIRN Cohort.
    Atia O, Friss C, Ledderman N, Greenfeld S, Kariv R, Daher S, Yanai H, Loewenberg Weisband Y, Matz E, Dotan I, Turner D.
    J Crohns Colitis; 2023 Nov 08; 17(10):1614-1623. PubMed ID: 37099729
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 18. Evidence-based efficacy of methotrexate in adult Crohn's disease in different intestinal and extraintestinal indications.
    Cassinotti A, Batticciotto A, Parravicini M, Lombardo M, Radice P, Cortelezzi CC, Segato S, Zanzi F, Cappelli A, Segato S.
    Therap Adv Gastroenterol; 2022 Dec 12; 15():17562848221085889. PubMed ID: 35340755
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials.
    Nielsen OH, Steenholdt C, Juhl CB, Rogler G.
    EClinicalMedicine; 2020 Mar 12; 20():100271. PubMed ID: 32300735
    [Abstract] [Full Text] [Related]

  • 20. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
    Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T, UK Inflammatory Bowel Disease Pharmacogenetics Study Group.
    Lancet Gastroenterol Hepatol; 2019 May 12; 4(5):341-353. PubMed ID: 30824404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.